Efficient manufacturing and engraftment of <i>CCR5</i> gene-edited HSPCs following busulfan conditioning in nonhuman primates.

Mol Ther Methods Clin Dev · 2023 · PMC10415663 · PMID 37575091

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

After 90 days post transplant, CCR5 editing in peripheral white blood cells ranged from 20% to 40% of alleles, which trended higher than HBG editing in the primed marrow/TBI cohort ( Figure 4 C) but did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.